Completed NA INTERVENTIONAL 2-arm NCT02166359

Effect of Extraneal (Icodextrin) on Triglyceride Levels in PD Patients

Sponsor: Baxter Healthcare Corporation

Interventions Extraneal (Icodextrin) Glucose solution

Updated 8 times since 2017 Last updated: May 27, 2019 Started: Jun 30, 2014 Primary completion: Mar 31, 2019 Completion: Apr 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02166359, this NA trial focuses on End Stage Renal Disease and remains completed. Sponsored by Baxter Healthcare Corporation, it has been updated 8 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2019 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed

▶ Show 3 earlier versions

Jun 2018 — Jun 2019 [monthly]

Recruiting NA
Apr 2018 — Jun 2018 [monthly]

Recruiting NA
Jan 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baxter Healthcare Corporation
Dong-A University

Data source: Dong-A University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Busan, South Korea